EVTM in Resuscitation Workflows
Applied
Type
ModificationConfidence
90%
Created
Mar 27, 2026
Evidence
2 sources
Rationale
The section was updated to include the most recent European guidelines (Rossaint 2023) which provide the current standard for trauma-induced coagulopathy and massive transfusion workflows. Additionally, registry data (Cralley 2026) was added to support the specific use of Zone I REBOA as a bridge maneuver in hemorrhagic shock. Abbreviations were expanded on first use as required.
Evidence
Content Changes
removedadded
<!-- type: algorithm --> **Table 16.2. Endovascular trauma management (EVTM) Resuscitation Workflow (Physiology-First, Time-to-Control)** [@trauma2016-endovascular] | **Phase** | **Action** | **Operational detail** | | --- | --- | --- | | Arrival | Activate trauma + DCRdamage control resuscitation (DCR) | Early massive transfusion pathway; prevent hypothermia; correct coagulopathy. [@spahn2019] [@rossaint2023-b] | | Arrival | Obtain access | Femoral arterial + venous access early when noncompressible torso hemorrhage (NCTH) is possible. [@bulger2019] | | Unstable + suspected NCTH | Bridge maneuver | resuscitative endovascular balloon occlusion of the aorta (REBOA) (Zone I or III) only if a rapid path to definitive control exists. [@bulger2019] [@cralley2026-c] | | Transient responder | Rapid imaging | computed tomography angiography (CTA) when hemodynamics allow to localize bleeding and plan endovascular vs open. | | Definitive hemorrhage control | Endovascular | Embolization for pelvic/solid organ bleeding; covered stent for junctional arterial disruption. [@coccolini2017-wses] [@markov2011] | | Definitive hemorrhage control | Open + endovascular | Hybrid OR: laparotomy/packing + angio/embolization/stent as needed. [@wses2018] | | Post-control | Transition to critical care | Occlusion deflation plan, metabolic management, limb/renal monitoring; staged definitive repair as physiology normalizes. [@bulger2019] | **Key workflow rule** REBOA and other EVTM tools are **not definitive therapy**; they are time-buying interventions that must shorten the interval to hemostasis, not prolong it. [@bulger2019] [@morrison2014] [@rossaint2023-b] Cross-reference: [[Damage Control Surgery]] and [[Massive Transfusion]]. [@spahn2019] [@rossaint2023-b]